Several studies have demonstrated evidence that MCP-1 directly acts on cancer cells via CCR2 and enhances survival, proliferation, and migration/invasion, contributing to the progression of BC; however, these CCL2 effects could not be recapitulated in studies using genetically engineered mouse models. Here, CCL2 is linked to breast cancer.